Therapeutical treatment with oligo-beta- (1,3) -glucans, drugs used in said treatment
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 24, 2005
app pub date -
Sep 23, 2003
filing date -
Sep 23, 2003
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A therapeutical method comprising administration of a composition comprising an amount of oligo-.beta.-(1,3)-glucan and a pharmaceutically acceptable carrier, to a human being or to a warm-blood animal suffering from a disease selected from the group consisting in a tumor, a cancer, a viral disease, a bacterial disease, a fungal disease, a disease of the immune system, an auto-immune disease or a disease related to a deficiency of immunostimulation, wherein the amount of oligo-.beta.-(1,3)-glucan is effective to treat the disease.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully